News

Investors Rally for Class Action Against Applied Therapeutics

Investors Rally for Class Action Against Applied Therapeutics

Investors Encourage Legal Action Against Applied Therapeutics

Recently, a group of investors interested in Applied Therapeutics, Inc. (NASDAQ: APLT) found themselves at a crossroads as significant losses prompted them to consider banding together for legal recourse. The announcement from Robbins Geller Rudman & Dowd LLP serves as a clarion call for those who acquired APLT securities between January 3, 2024, and December 2, 2024, to consider stepping up as lead plaintiffs in a new class action lawsuit.

The Opportunity to Lead in the Class Action

The class action lawsuit, titled Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), alleges serious violations of the Securities Exchange Act of 1934. Investors who experienced substantial financial losses during this period have a unique opportunity to seek appointment as lead plaintiffs and take action against the company for its alleged misleading statements and failure to follow clinical protocols.

Details Surrounding the Class Action Lawsuit

The complaint highlights major concerns about Applied Therapeutics' adherence to trial protocols. On January 3, 2024, the firm announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for govorestat, aiming to treat Classic Galactosemia. However, the class action accuses defendants of knowingly misrepresenting the company’s adherence to regulatory standards, thus hiding the potential for the NDA to be rejected.

Exposing the Risks of Misrepresentation

The stakes became even clearer with a significant reveal on November 27, 2024, when the FDA delivered a Complete Response Letter regarding the NDA, indicating that it could not be approved in its current form due to various deficiencies. Following this disclosure, the price of APLT shares plummeted by over 80% across three trading sessions, showcasing the severe impact of these allegations on investors.

Further Complications Highlighted

The situation worsened when, on December 2, 2024, Applied Therapeutics publicly admitted to receiving an FDA warning. The issues cited included problems with electronic data capture and a dosing error during the clinical study phase. This added complexity led to another significant drop of more than 26% in share prices over the following days, indicating that investors faced a catastrophic impact on their holdings.

Understanding the Lead Plaintiff Process

Under the Private Securities Litigation Reform Act of 1995, any investor who purchased APLT securities during the defined class period has the right to pursue being appointed as a lead plaintiff in the class action. Lead plaintiffs will represent the interests of all class members, utilizing the guidance of their chosen legal representation. Importantly, individual investors’ chances for sharing in potential recoveries remain intact regardless of whether they do take on this leadership role.

The Role of Robbins Geller Rudman & Dowd LLP

Robbins Geller is recognized as one of the top law firms fighting for investor rights. With an impressive history of securing substantial settlements in securities fraud cases, the firm has a proven track record of representing victims effectively. They have successfully recovered over $6.6 billion for investors, reinforcing their position as a formidable ally in navigating complex legal battles. Investors considering participation in the class action can reach out to J.C. Sanchez or Jennifer N. Caringal for assistance in understanding their options.

Contact Details for Further Assistance

For inquiries, contact Robbins Geller at 800-449-4900 or via email at info@rgrdlaw.com. Those interested in joining the class action or needing more information should not hesitate to engage with the experienced team.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit against Applied Therapeutics involves allegations of misleading statements and violations of the Securities Exchange Act related to their New Drug Application process.

Who is eligible to be a lead plaintiff?

Any investor who purchased APLT securities during the defined class period is eligible to seek appointment as lead plaintiff in the lawsuit.

What happened to APLT's stock price?

After the FDA's response regarding the NDA and subsequent disclosures, APLT's stock experienced significant declines, dropping over 80% and later more than 26% in rapid succession.

How can investors get involved?

Investors can reach out to Robbins Geller for guidance on how to participate in the class action and possibly become a lead plaintiff.

What services does Robbins Geller offer?

Robbins Geller provides legal support and representation for investors in securities fraud cases, helping them secure a fair outcome for their losses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 220

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 263

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 82

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 118

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Common Tiger Bets $499 on Better Outdoor Seating Design

Updated Category News Views 26

A chair that refuses to slump into the camping aisle is Common Tiger's whole argument, and frankly it is a smarter argument than another flimsy fold-up contraption pretending comfort is optional. The Los Angeles, female-founded and women-owned brand is launching with one product, The Daymaker, after four years of development. That is a long runway for a debut chair, which...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 8

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 194

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 26

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 86

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
Lotte's Songdo Plant 1 Puts 120,000 Liters on Deck

Updated Category News Views 68

A 120,000-liter biomanufacturing plant is not a ribbon-cutting trinket; it is a serious industrial bet that has to earn its keep one qualified batch at a time. LOTTE Biologics has completed Plant 1 at its Songdo Bio Campus in Incheon, South Korea, giving the company a sizable new production base as it tries to become a more consequential player in the global CDMO...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into Abacus Global Management Inc. Stock

Updated Category News Views 231

Wolf Popper LLP Initiates Investigation for Investors In response to potential investor claims, Wolf Popper LLP has begun an investigation concerning the common stock of Abacus Global Management, Inc. (ABL). This action comes in light of significant recent developments that have raised concerns among shareholders. Background on Abacus Global Management Abacus Global...

Continue Reading
LM Funding America Inc. Reports Q3 2024 Results and Outlook

Updated Category News Views 115

Business Update and Financial Highlights LM Funding America, Inc. (NASDAQ: LMFA) has recently shared its financial results for the third quarter of 2024. This Tampa-based company focuses on cryptocurrency mining and technological finance solutions, showcasing significant strategic developments in its operations. Bitcoin Holdings and Revenue Performance As of September 30,...

Continue Reading
Siete Foods' Juntos Fund Celebrates 15 Latino-Owned Businesses

Updated Category News Views 239

Siete Foods launched its Juntos Fund back in 2024, dishing out a hefty $300,000 to uplift Latino small business owners. This initiative aimed at breaking down barriers for Latino entrepreneurs who often struggle to secure the financial backing they need. The winners? A mix of vibrant eateries and innovative food ventures that embody the rich essence of Latino culture...

Continue Reading
Discover the Fascinating Marilyn Monroe in New Documentary

Updated Category News Views 319

Big Screen Entertainment Group Unveils Marilyn Monroe Documentary Big Screen Entertainment Group (OTC: BSEG) has generated excitement with the release of its first trailer for an upcoming documentary focusing on the legendary actress Marilyn Monroe. This film, titled "Hollywood Legends: The Marilyn Monroe Story," promises to be a captivating tribute that delves into not...

Continue Reading
Transforming Dealerships: FrogData's New Marketing Solution

Updated Category News Views 120

FrogData Introduces FixedOps Velocity for Dealerships FrogData, a leader in advanced data analytics for the automotive industry, has recently launched a groundbreaking marketing solution called FixedOps Velocity. This innovative platform is aimed at helping dealership service departments enhance their marketing strategies significantly. The announcement comes just ahead...

Continue Reading